IMMULABS CORPORATION

                                Filing Type: 8-K
                           Description: Current Report
                          Filing Date: December 5, 2002
                          Period End: December 5, 2002

            Primary Exchange: Over the Counter Includes OTC and OTCBB
                                  Ticker: IMLB






- --------------------------------------------------------------------------------

                                Table of Contents

- --------------------------------------------------------------------------------


                                       8-K

ITEM 5.........................................................................1




- --------------------------------------------------------------------------------



                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

      Pursuant to Section 13 or 15d of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): December 5, 2002


                              IMMULABS CORPORATION
             (Exact name of registrant as specified in its charter)



         Colorado                    0-26760                     84-1286065
 (State of Incorporation)          (Commission               (I.R.S   Employer
                                   File Number)              Identification No.)


              Suite 132-3495 Cambie St. Vancouver BC Canada V5Z 4R3
               (Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code (604) 696-0073





              (Former name, former address and former fiscal year,
                         if changed since last report.)



- --------------------------------------------------------------------------------

ITEM 5.  OTHER EVENTS.

         The  Company is  currently  in  negotiations  with a  potential  merger
partner. The Board has authorized the issuance of two million post-reverse split
restricted shares for a potential partner,  to be held in trust with a law firm.
Since his recent  appointment,  the  President  of Immulabs  has not  received a
salary  from the  Company.  To  compensate  him,  the Board has  authorized  the
issuance  of 10,000  stock  options to him with an  exercise  price of $4.00 per
share.

- --------------------------------------------------------------------------------



                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                       Date: December 5, 2002

                                       IMMULABS CORPORATION








                                       By: /s/ Ben Traub
                                          ------------------
                                          Ben Traub
                                          President